Signal-based GTM.
Pipeline for life sciences.

Signal-based GTM.
Pipeline for
life sciences.

Reaching buyers when it's relevant. Opportunities Sales actually accepts.

Reaching buyers when
it's relevant.
Opportunities
that Sales accepts.

CHF 0M+Pipeline generated

0%Lead acceptance

CHF 0M+Pipeline generated

0%Lead acceptance

MedTech

TechBio

CDMO / CRO

RWD

CDMO / CRO

RWD

Book your intro call

Our latest case study

• Case study

The Relevance Crisis

Everyone reaches everyone with the same message.

What you get

We don't do volume.

We do pipeline.

We dig into your market with signal-based targeting — finding the accounts showing signals of pain, the ones your solution is relevant to right now.

Then we run the outreach end to end, and hand over sales opportunities your team confirms. Accepted 90%+ of the time across programs.

Signal-based targeting

Research

We find who's in pain now.

We dig through niche, often hard-to-find data sources to find the accounts for whom your solution is relevant today. (from hundreds of thousands down to a few hundred)

Signal-based targeting

Research

We find who's in pain now.

We dig through niche, often hard-to-find data sources to find the accounts for whom your solution is relevant today. (from hundreds of thousands down to a few hundred)

Multichannel outreach

Execution

We build it, run it, and tune until it clicks.

Outreach live by day 15, full capacity by day 30. We launch and adjust (angles, formats, segments) week after week. You sign off the messages while we handle the rest.

90%+ Acceptance

Pipeline Opportunities

We hand over real opportunities.

Lower volume and higher quality by design (right person, right company, real fit). Fewer. Qualified. Accepted 90% of the time.

Skin in the Game

Shared-Risk Model

We get paid on performance.

We work on a hybrid model, a base fee plus performance fee, on leads you validate.

What they say

Real pipeline opportunities, delivered.

Accepted 95% of the time.

Accepted 95%
of the time.

Book a call

“Before LF Mate, we had the right product but no way to reach the right practices at scale. In 90 days, they built us a $13.5M qualified pipeline in a US market we just started to enter, and ran every step of the outbound themselves.”
Stefan Bircher
CBDMO
Positrigo
“Thanks to LF Mate's creative work on lead magnets and email content, we were able to reach more people — and grow our mailing list by more than 15%.”
Dr. Daniel Black
Co-President
Leben mit Lungenkrebs
“LF Mate understood our HealthTech reality from day one. They care about the project succeeding, even more than their own timeline. They're not another GTM Agency. We'd work with them again 100%.”
Ignacio Medina
Co-founder & CTO
Appunto
“Before our collaboration with LF Mate, we were cold pitching and hearing crickets. They built our Warm up engine from scratch. We closed one of our first paying customers.”
Ilya Schneider
Co-Founder & BD
Hephaistos

“Before LF Mate, we had the right product but no way to reach the right practices at scale. In 90 days, they built us a $13.5M qualified pipeline in a US market we just started to enter, and ran every step of the outbound themselves.”
Stefan Bircher
CBDMO
Positrigo
“Thanks to LF Mate's creative work on lead magnets and email content, we were able to reach more people — and grow our mailing list by more than 15%.”
Dr. Daniel Black
Co-President
Leben mit Lungenkrebs
“LF Mate understood our HealthTech reality from day one. They care about the project succeeding, even more than their own timeline. They're not another GTM Agency. We'd work with them again 100%.”
Ignacio Medina
Co-founder & CTO
Appunto
“Before our collaboration with LF Mate, we were cold pitching and hearing crickets. They built our Warm up engine from scratch. We closed one of our first paying customers.”
Ilya Schneider
Co-Founder & BD
Hephaistos

“Forget basic ebooks — Lf mate created a high-performing lead magnet from scratch, along with its promotion plan. It became the most successful lead magnet I’ve launched.”
Andrea Born-Cristancho
Director
Born Partners
"The LF Mate team delivered immediate impact for us, not only by increasing outbound activity, but by improving the quality of engagement with the right ICPs. For an early-stage commercial effort, that level of precision matters. We’re excited to continue scaling with the team”
Brian Oswald
VP US Sales
Positrigo
“They put our success first. Not their invoices. LF Mate helped us build a proper Go-To-Market engine from scratch. In niche markets like ours, generic doesn't work.”
Antonio Mateos
Co-founder & CEO
QUAI
“Matias’ hands-on approach to defining our ICP and launching our first targeted paid campaigns outperformed our manual efforts, driving growth we couldn’t achieve internally.”
Matthieu Ochsner
Co-founder & CEO
GoNina

“Forget basic ebooks — Lf mate created a high-performing lead magnet from scratch, along with its promotion plan. It became the most successful lead magnet I’ve launched.”
Andrea Born-Cristancho
Director
Born Partners
"The LF Mate team delivered immediate impact for us, not only by increasing outbound activity, but by improving the quality of engagement with the right ICPs. For an early-stage commercial effort, that level of precision matters. We’re excited to continue scaling with the team”
Brian Oswald
VP US Sales
Positrigo
“They put our success first. Not their invoices. LF Mate helped us build a proper Go-To-Market engine from scratch. In niche markets like ours, generic doesn't work.”
Antonio Mateos
Co-founder & CEO
QUAI
“Matias’ hands-on approach to defining our ICP and launching our first targeted paid campaigns outperformed our manual efforts, driving growth we couldn’t achieve internally.”
Matthieu Ochsner
Co-founder & CEO
GoNina

• Case study

Who we are

We're LF Mate.
A Swiss GTM agency

Life sciences is what we do.

Matías

GTM Lead

Cristina

Scientific Advisor

Martina

Operations & Design

Eduardo

GTM Engineering

Proficient in English, Spanish, German, French

Why us

You only pay for pipeline

you'd pay for.

Leads your sales team actually accepts. Fewer, and qualified. (90%+ acceptance rate)

The signals we track are niche, segment-specific, and nuanced. That's why we specialize in life sciences.

Our model is hybrid: a base fee plus a success fee per opportunity. We hand over the opportunity, you have the sales call, you decide if it's a fit.

For complex sales cycles, technical buyers, and high value deals.

Ready to accelerate your pipeline?

Book a call

Why us

You only pay for pipeline

you'd pay for.

Leads your sales team actually accepts. Fewer, and qualified. (90%+ acceptance rate)

The signals we track are niche, segment-specific, and nuanced. That's why we specialize in life sciences.

Our model is hybrid: a base fee plus a success fee per opportunity. We hand over the opportunity, you have the sales call, you decide if it's a fit.

For complex sales cycles, technical buyers, and high value deals.

Ready to accelerate your pipeline?

Book a call

Why us

Signal-based GTM.Pipeline for life sciences.

Signal-based GTM.Pipeline for life sciences.

Reaching buyers when it's relevant. Opportunities Sales actually accepts.

Reaching buyers when it's relevant. Opportunities that Sales accepts.

Everyone reaches everyone with the same message.

We don't do volume.

We do pipeline.

Research

We find who's in pain now.

Research

We find who's in pain now.

Execution

We build it, run it, and tune until it clicks.

Pipeline Opportunities

We hand over real opportunities.

Shared-Risk Model

We get paid on performance.

Real pipeline opportunities, delivered.

Accepted 95% of the time.

Accepted 95% of the time.

We're LF Mate. A Swiss GTM agency

Life sciences is what we do.

You only pay for pipeline

you'd pay for.

Leads your sales team actually accepts. Fewer, and qualified. (90%+ acceptance rate)

The signals we track are niche, segment-specific, and nuanced. That's why we specialize in life sciences.

Our model is hybrid: a base fee plus a success fee per opportunity. We hand over the opportunity, you have the sales call, you decide if it's a fit.

For complex sales cycles, technical buyers, and high value deals.

Ready to accelerate your pipeline?

You only pay for pipeline

you'd pay for.

Leads your sales team actually accepts. Fewer, and qualified. (90%+ acceptance rate)

The signals we track are niche, segment-specific, and nuanced. That's why we specialize in life sciences.

Our model is hybrid: a base fee plus a success fee per opportunity. We hand over the opportunity, you have the sales call, you decide if it's a fit.

For complex sales cycles, technical buyers, and high value deals.

Ready to accelerate your pipeline?

You only pay for pipeline

you'd pay for.

Leads your sales team actually accepts. Fewer, and qualified. (90%+ acceptance rate)

The signals we track are niche, segment-specific, and nuanced. That's why we specialize in life sciences.

Our model is hybrid: a base fee plus a success fee per opportunity. We hand over the opportunity, you have the sales call, you decide if it's a fit.

For complex sales cycles, technical buyers, and high value deals.

Ready to accelerate your pipeline?

Frequently asked

Questions

What exactly means "pipeline opportunity"?

How fast do we see results?

How much work is this on our side?

How are you different from other lead gen agencies?

How does pricing work?

What exactly means "pipeline opportunity"?

How fast do we see results?

How much work is this on our side?

How are you different from other lead gen agencies?

How does pricing work?

Signal-based GTM.
Pipeline for life sciences.

Signal-based GTM.
Pipeline for
life sciences.

Reaching buyers when
it's relevant.
Opportunities
that Sales accepts.

Accepted 95%
of the time.

We're LF Mate.
A Swiss GTM agency